942 related articles for article (PubMed ID: 27241814)
1. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
2. [Vogt-Koyanagi-Harada disease].
Bonnet C; Daudin JB; Monnet D; Brézin A
J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
4. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
Inomata H; Rao NA
Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
6. [Vogt-Koyanagi-Harada disease].
Kjeka O; Krohn J
Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
9. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
Vasconcelos-Santos DV; Sohn EH; Sadda S; Rao NA
Retina; 2010 Jan; 30(1):33-41. PubMed ID: 20010321
[TBL] [Abstract][Full Text] [Related]
10. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada syndrome in a 4-year old child.
Cunningham ET; Demetrius R; Frieden IJ; Emery HM; Irvine AR; Good WV
Am J Ophthalmol; 1995 Nov; 120(5):675-7. PubMed ID: 7485374
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Martin TD; Rathinam SR; Cunningham ET
Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
[TBL] [Abstract][Full Text] [Related]
13. New insights into Vogt-Koyanagi-Harada disease.
Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH
Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980
[TBL] [Abstract][Full Text] [Related]
14. Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome.
Wong RK; Lee JK; Huang JJ
Retin Cases Brief Rep; 2012; 6(4):423-6. PubMed ID: 25389947
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
16. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].
Zheng YZ
Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816
[TBL] [Abstract][Full Text] [Related]
17. [A rare case of ocular scarrings in a patient with Vogt-Koyanagi-Harada disease].
Belmokhtar A; Daoudi R
Pan Afr Med J; 2017; 28():313. PubMed ID: 29721143
[TBL] [Abstract][Full Text] [Related]
18. [Vogt-Koyanagi-Harada syndrome in children].
Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
[TBL] [Abstract][Full Text] [Related]
19. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
20. Vogt Koyanagi Harada disease: treatment and visual prognosis.
Alam M; Iqbal M; Khan BS; Hussain I
J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
